Aims To evaluate if ticagrelor, an effective platelet inhibitor without known non-responders,
could inhibit growth of small abdominal aortic aneurysms (AAAs). Methods and results In this …

The physiological transport in the aortic wall occurs mainly by centrifugal convection from
the lumen to the adventitia through the arterial wall. Enlargement of an abdominal aortic …

Background Management of abdominal aortic aneurysms (AAAs) relies on surgical repair of
larger AAAs. Consequently medical interventions inhibiting AAA progression could greatly …

Objective There is no medical treatment proven to limit abdominal aortic aneurysm (AAA)
progression. This systematic review aimed to summarise available trial evidence on the …

Background No effective treatment is currently available to prevent progression of small and
medium-sized abdominal aortic aneurysms (AAAs). Identification of drugs with sufficient …

Background Pharmacotherapy may represent a potential means to limit the expansion rate
of abdominal aortic aneurysms (AAAs). Studies evaluating the efficacy of different …

Background Most current evidence examining abdominal aortic aneurysm (AAA) growth is
based on ultrasound surveillance. Objective This review aimed to systematically analyse …

OBJECTIVE: Evidence regarding the influence of cardiovascular risk factors, comorbidities,
and patient characteristics on the growth of small abdominal aortic aneurysms (AAA) is …

Importance Currently there is no drug therapy for abdominal aortic aneurysm (AAA).
Objective To test the efficacy of the angiotensin receptor blocker telmisartan in slowing AAA …

Objective This review describes ongoing efforts to develop a medical therapy to limit
abdominal aortic aneurysm (AAA) growth. Methods Data from animal model studies, human …